Focused ultrasound for liver tumors near major blood vessels
Part of Cancer, Digestive system clinical trials.
This trial tests a focused ultrasound therapy called histotripsy to destroy liver tumors that are close to major blood vessels and cannot be surgically removed. The goal is to see if this non-invasive approach is safe and effective for tumors that are otherwise hard to treat.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with liver cancer or a tumor that has spread to the liver.
- You are not eligible for surgery because the tumor is less than 1 cm (about the width of a pea) from major blood vessels in the liver.
- You have at least one tumor, but no more than three, and each tumor is 5 cm (about 2 inches) or smaller.
- Your liver function is adequate (Child-Pugh class A or B), and your overall health is good enough to undergo general anesthesia.
- You have not had radiation therapy within 30 days before or after this treatment, and you are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a needle-based device that uses heat or cold to destroy liver tumors. It is for people with primary or secondary liver cancer who cannot have surgery or a transplant.
This study tests a new, noninvasive treatment called histotripsy that uses sound waves to destroy small liver tumors. It is for people whose liver cancer hasn't spread much and who haven't had success with or can't have surgery or other standard treatments.
This trial tests a non-invasive treatment using sound waves (histotripsy) to break up tumors in the abdomen without surgery, aiming to reduce symptoms and improve quality of life. It is designed for people whose tumors cannot be removed surgically.
This trial tests a new device that uses sound waves to destroy liver tumors without cutting or needles. It may be an option if you have a liver tumor that can be partly or fully targeted by this technique.
This trial tests a new treatment that combines a special type of focused ultrasound (called histotripsy) with an immune checkpoint inhibitor to boost the immune system's attack on cancer. It is for people with advanced cancer that has not responded to standard treatments.
This study tests a new, more detailed ultrasound technique to better see liver tumors. It may help doctors understand your tumor better without extra procedures.
Hear when a new Liver Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.